AtriCure: Committed to Atrial Fibrillation Treatment and Solutions
AtriCure is your partner in atrial fibrillation solutions. Our research and rigorous atrial fibrillation clinical trials have led to innovations in ablation technology, including bi-polar and cryoablation, to treat atrial fibrillation with lasting solutions. Our Synergy Ablation System is the first and only device approved by the Food and Drug Administration for the surgical treatment of atrial fibrillation in patients undergoing open heart procedures simultaneously. In addition, we pioneered the AtriClip®, a left atrial appendage occlusion, device that is the most widely implanted for left atrial appendage management worldwide. It is our passion to collaborate with surgeons to make surgeries like the Maze IV simpler to perform and reproducible by more doctors around the world. Through continued commitment to product innovation and education grounded in clinical science, we’re working to reduce the global atrial fibrillation epidemic.